A local pharmaceutical company has partnered with an innovative tech company to launch a new app geared to help parents take better care of children with attention deficit hyperactivity disorder (ADHD).
Pharma Dynamics introduced the app to empower families and the broader care team of children with ADHD to navigate their care journey through collaborative information sharing.
Abdurahmaan Kenny, central nervous system portfolio manager for Pharma Dynamics, explained the innovative solution allows parents to invite teachers, health-care professionals and child-care teams to monitor symptoms and side-effects collaboratively, stay on track by setting reminders for medication, activities and assessments, and keep a digital history of a child’s care journey and response to stimuli.
“Beyond medication and behavioural therapy, a well-coordinated care team is at the heart of an effective treatment plan for children with ADHD,” he pointed out. “Dealing with the condition does not only pose challenges for the diagnosed child, but also families and educators can take strain if the patient is not well managed.”
Kenny highlighted the following five components co-ordinated in the app to benefit the patient and the care team: . when and how to administer medication;. monitor and track changes in your child’s symptoms and behaviour;. activity ideas;. digital assessments; and. history of your child’s care journey.
Parents and caregivers will be able to track seven symptoms, such as anxiety, appetite, sleep, hyperactivity, ability to listen, mood and concentration. Expansion of further symptoms are still underway. It can also be configured to support a child’s specific needs at any point along his or her journey.
The solution was developed in partnership with Augmental Technologies, in collaboration with leading clinical and educational psychiatrists, sleep specialists and occupational therapists to empower parents and healthcare practitioners with the right information to give children with ADHD the best care.
“The solution is intended to close the loop and enable parents, educators and caregivers to be just as engaged in the treatment programme as the child is,” Kenny added. “It’s primarily intended to support families with ADHD children from 4 to 13 years of age, and can be accessed by scanning the QR code on all relevant ADHD medication distributed by Pharma Dynamics.”